Assertio Holdings inc (ASRT) - News Archive

: Assertio Holdings, Inc., a prominent pharmaceutical company, is poised to present new findings from a real-world evidence study concerning SYMPAZAN (clobazam) Oral Film at the 150th Annual Meeting of the American Neur...

: The therapeutic landscape for oncology patients necessitates innovative solutions that ensure efficacy, safety, and practicality in the administration of supportive care treatments. In an effort to enhance patient con...

Assertio Holdings: Strategic Leadership Changes and Clinical Innovations in Oncology Amid ChallengesAssertio Holdings, Inc. a notable player in the pharmaceutical landscape, is gearing up for a pivotal shift under new l...

In the fast-paced landscape of pharmaceuticals, assertions can ripple through markets and affect not just individual companies, but entire sectors. Recently, a press release from Assertio Holdings drew attention, addres...

In recent developments, Assertio Holdings, Inc. has disclosed the approval of inducement grants in compliance with NASDAQ Listing Rule 5635(c)(4). While these inducement grants typically aim to attract and retain essent...

Assertio Holdings, Inc. recently granted RSUs and stock options to newly-hired employees in accordance with NASDAQ Listing Rule 5635(c)(4). The company, known for its comprehensive commercial capabilities in the pharmac...

Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)LAKE FOREST, Ill., June 06, 2024 - Assertio Holdings, Inc. (Assertio or the Company) (NASDAQ: ASRT), a pharmaceutical company known f...

Assertio Holdings, Inc. (NASDAQ: ASRT), a prominent specialty pharmaceutical company, recently disclosed inducement grants awarded to two newly-hired employees. The Compensation Committee of the Company s Board of Direc...